New study tracks Real-World effects of CF drugs on patients

This study followed 58 adults with cystic fibrosis who were starting or switching to newer CFTR modulator drugs as part of their regular care. Researchers collected blood, sputum, urine, and quality-of-life surveys before and after treatment to see how inflammation, lung bacteria, and lung function changed over time. The goal was to better understand the long-term effects of these advanced therapies on the disease.